1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APELLIS PHARMACEUTICALS INC
Apellis Pharmaceuticals Inc XNAS: APLS
28.17 0.60 (2.18%)
1.9M
XNAS Volume

XNAS 02 Sep, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Apellis Pharmaceuticals Inc is on 09 Sep 2025 for the purpose of Baird Global Healthcare Conference See details

Apellis Pharmaceuticals Inc - APLS - stock price prediction, stock price target, analyst ratings from 21 analysts

Apellis Pharmaceuticals Inc has a share price target of US$ 39, revenue growth forecast of 19.2%, and profit growth estimate of 78.9% for FY25, based on top 21 analyst calls.